Shattuck Labs STTK
NASDAQ STTK
$6.79 -0.17 (-2.44%)
As of: Sep 4, 2026 · 3:59 PM EDT

Shattuck Labs (STTK) Change in Accured Expenses (2019 - 2026)

Shattuck Labs (STTK) posted quarterly Change in Accured Expenses of -$2.0 million for Q1 2026, down 173.04% year-over-year from $2.7 million in Q1 2025, and down 321.66% quarter-over-quarter from $882000.0 in Q4 2025.

Analysis

Shattuck Labs (STTK) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has reported Change in Accured Expenses for 8 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 173.04% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$2.7 million (down 25.87% YoY), while the FY2025 annual figure was -$1.4 million, up 57.19% from the prior year.
  • Change in Accured Expenses slipped to -$2.0 million in Q1 2026 per STTK's latest filing, from $882000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $4.1 million in Q2 2022 and bottomed at -$7.4 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged -$710764.7 across 5 years, with a median of -$687000.0 in 2025.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses tumbled 1123.96% — and 2024, when it soared 923.12%.
  • Shattuck Labs' Change in Accured Expenses stood at $1.9 million in 2022, then plunged by 206.91% to -$2.0 million in 2023, then sank by 45.81% to -$3.0 million in 2024, then surged by 129.64% to $882000.0 in 2025, then plunged by 321.66% to -$2.0 million in 2026.
  • Business Quant data shows STTK's Change in Accured Expenses at -$2.0 million in Q1 2026, $882000.0 in Q4 2025, and -$687000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Shattuck Labs 885.09 Mn 885.09 Mn - 793,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 793,000.00
Mar 31, 2026 -1.96 Mn
Dec 31, 2025 882,000.00
Sep 30, 2025 -687,000.00
Jun 30, 2025 -921,000.00
Mar 31, 2025 -716,000.00
Dec 31, 2024 -2.98 Mn
Sep 30, 2024 -76,000.00
Jun 30, 2024 1.64 Mn
Mar 31, 2024 -1.95 Mn
Dec 31, 2023 -2.04 Mn
Sep 30, 2023 1.30 Mn
Jun 30, 2023 -199,000.00
Mar 31, 2023 -7.36 Mn
Dec 31, 2022 1.91 Mn
Sep 30, 2022 -2.47 Mn
Jun 30, 2022 4.14 Mn
Mar 31, 2022 -601,000.00
Dec 31, 2021 493,000.00
Sep 30, 2021 2.46 Mn